Platelet glycoprotein IIb/IIIa inhibition during percutaneous coronary revascularization: what more needs to be proven?

Randomised clinical trial: gastrointestinal events in arthritis patients treated with celecoxib, ibuprofen or naproxen in the PRECISION trial.

Alimentary pharmacology & therapeutics·2018

Clinical experience with abciximab during coronary revascularisation: an overview.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2007

Clinical end point definitions after percutaneous coronary intervention and their relationship to late mortality: an assessment by attributable risk.

Heart (British Cardiac Society)·2006

First experience with direct, selective factor Xa inhibition in patients with non-ST-elevation acute coronary syndromes: results of the XaNADU-ACS Trial.

Journal of thrombosis and haemostasis : JTH·2005

Initial experience with factor-Xa inhibition in percutaneous coronary intervention: the XaNADU-PCI Pilot.

Journal of thrombosis and haemostasis : JTH·2004

Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes.

European heart journal·2004

Genotype and arrhythmic risk in dilated cardiomyopathy.

European heart journal·2026

Palmitic acid promotes hypertrophic memory in cardiomyocytes via KDM5A/H3K4me3.

European heart journal·2026

Reducing the burden of heat-related impacts on cardiovascular health.

European heart journal·2026

Ameliorative effects and mechanisms of paeonol against rosacea through network pharmacology and experimental validation.

Frontiers in immunology·2026

Searching for Novel COVID19 Treatments: Towards Covalent TMPRSS2 Inhibitors.

ChemMedChem·2026

Molecular Recognition and Immunopharmacological Implications of Serratiopeptidase Targeting Snake Venom Bradykinin-Potentiating Peptides.

Pharmaceutical research·2026

Interpretable machine learning framework for peptide lead optimization in ultralarge design spaces.

npj drug discovery·2026

Bioinformatics-driven discovery of bioactive natural peptides from cyanobacterial genomes.

Bioresource technology·2026

Non-covalent complexes of Chlorella pyrenoidosa antioxidant peptides with chlorogenic acid: structure-activity relationships and potential synergistic cytoprotection.

Food chemistry·2026

Related Experiment Videos

Platelet glycoprotein IIb/IIIa inhibition during percutaneous coronary revascularization: what more needs to be

Related Concept Videos

Randomised clinical trial: gastrointestinal events in arthritis patients treated with celecoxib, ibuprofen or naproxen in the PRECISION trial.

Clinical experience with abciximab during coronary revascularisation: an overview.

Clinical end point definitions after percutaneous coronary intervention and their relationship to late mortality: an assessment by attributable risk.

First experience with direct, selective factor Xa inhibition in patients with non-ST-elevation acute coronary syndromes: results of the XaNADU-ACS Trial.

Initial experience with factor-Xa inhibition in percutaneous coronary intervention: the XaNADU-PCI Pilot.

Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes.

Genotype and arrhythmic risk in dilated cardiomyopathy.

Palmitic acid promotes hypertrophic memory in cardiomyocytes via KDM5A/H3K4me3.

Reducing the burden of heat-related impacts on cardiovascular health.

Ameliorative effects and mechanisms of paeonol against rosacea through network pharmacology and experimental validation.

Searching for Novel COVID19 Treatments: Towards Covalent TMPRSS2 Inhibitors.

Molecular Recognition and Immunopharmacological Implications of Serratiopeptidase Targeting Snake Venom Bradykinin-Potentiating Peptides.

Interpretable machine learning framework for peptide lead optimization in ultralarge design spaces.

Bioinformatics-driven discovery of bioactive natural peptides from cyanobacterial genomes.

Non-covalent complexes of Chlorella pyrenoidosa antioxidant peptides with chlorogenic acid: structure-activity relationships and potential synergistic cytoprotection.

Related Experiment Videos

Platelet glycoprotein IIb/IIIa inhibition during percutaneous coronary revascularization: what more needs to be...

Related Concept Videos

Related Articles

Platelet glycoprotein IIb/IIIa inhibition during percutaneous coronary revascularization: what more needs to be